Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.370
-0.010 (-0.30%)
Jul 29, 2026, 4:00 PM EDT - Market closed
Cryo-Cell International Income Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
| 31.13 | 31.57 | 31.99 | 31.34 | 30.34 | 28.88 | |
Revenue Growth | -2.69% | -1.31% | 2.05% | 3.32% | 5.03% | -7.26% |
Cost of Revenue | 6.87 | 7.38 | 7.95 | 8.39 | 8.79 | 8.99 |
Gross Profit | 24.26 | 24.19 | 24.04 | 22.95 | 21.54 | 19.9 |
Selling, General & Admin | 18.95 | 18.22 | 18.52 | 17.17 | 15.58 | 14.61 |
Depreciation & Amortization Expenses | 0.74 | 0.75 | 0.48 | 1.12 | 1.12 | 0.83 |
Research & Development | 0.31 | 0.38 | 1.24 | 1.17 | 0.38 | 0.05 |
Other Operating Expenses | - | 4.36 | 0.31 | 15.79 | 0.44 | 0.38 |
Total Operating Expenses | 20 | 23.71 | 20.56 | 35.26 | 17.52 | 15.88 |
Operating Income | -0.1 | 0.48 | 3.48 | -12.3 | 4.02 | 4.02 |
Interest Expense | -1.92 | -2.07 | -1.86 | -1.24 | -1.52 | -1.38 |
Other Non-Operating Income (Expense) | -0.52 | -0.75 | 1.19 | 0.18 | 0.82 | -0.03 |
Total Non-Operating Income (Expense) | -2.44 | -2.82 | -0.68 | -1.06 | -0.71 | -1.41 |
Pretax Income | -2.55 | -2.34 | 2.8 | -13.36 | 3.32 | 2.61 |
Provision for Income Taxes | -0.08 | 0.09 | 2.4 | -3.84 | 0.55 | 0.53 |
Net Income | -2.47 | -2.43 | 0.4 | -9.52 | 2.77 | 2.08 |
Net Income to Common | -2.47 | -2.43 | 0.4 | -9.52 | 2.77 | 2.08 |
Net Income Growth | - | - | - | - | 33.02% | -42.52% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Change | -1.23% | -1.75% | -1.54% | -1.69% | 1.46% | 2.72% |
EPS (Basic) | -0.30 | -0.30 | 0.05 | -1.14 | 0.33 | 0.26 |
EPS (Diluted) | -0.30 | -0.30 | 0.05 | -1.14 | 0.33 | 0.25 |
EPS Growth | - | - | - | - | 32.00% | -44.44% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Free Cash Flow | 6.11 | 5.25 | 3.61 | 2.08 | -3.6 | 6.09 |
Free Cash Flow Growth | 2.91% | 45.49% | 73.36% | - | - | -27.19% |
Free Cash Flow Per Share | 0.76 | 0.65 | 0.44 | 0.25 | -0.42 | 0.73 |
Dividends Per Share | - | 0.400 | 0.250 | - | - | - |
Dividend Growth | - | 60.00% | - | - | - | - |
Gross Margin | 77.93% | 76.63% | 75.15% | 73.23% | 71.02% | 68.88% |
Operating Margin | -0.33% | 1.53% | 10.88% | -39.26% | 13.27% | 13.91% |
Profit Margin | -7.92% | -7.70% | 1.26% | -30.38% | 9.14% | 7.21% |
FCF Margin | 19.63% | 16.63% | 11.28% | 6.64% | -11.85% | 21.09% |
EBITDA | 0.87 | 1.47 | 4.17 | -10.9 | 5.52 | 5.06 |
EBITDA Margin | 2.80% | 4.65% | 13.05% | -34.79% | 18.21% | 17.51% |
EBIT | -0.1 | 0.48 | 3.48 | -12.3 | 4.02 | 4.02 |
EBIT Margin | -0.33% | 1.53% | 10.88% | -39.26% | 13.27% | 13.91% |
Effective Tax Rate | 3.20% | -3.95% | 85.66% | 28.75% | 16.50% | 20.21% |